Hepatitis A Synthetic Peptide VP3(110–121) Miscibility with Dipalmitoylphosphatidylcholine, Dipalmitoylphosphatidylglycerol, and Stearylamine Monolayers
- 1 January 2000
- journal article
- Published by Elsevier in Journal of Colloid and Interface Science
- Vol. 221 (2) , 230-235
- https://doi.org/10.1006/jcis.1999.6585
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Physico-chemical characterization of liposomes with covalently attached hepatitis A VP3(101–121) synthetic peptide†The Analyst, 1998
- Interaction of the Hepatitis A peptide VP3(110–121) with lipid mono and bilayer models of cellular membranesColloid and Polymer Science, 1997
- Immunogenicity of new heterobifunctional cross-linking reagents used in the conjugation of synthetic peptides to liposomesJournal of Immunological Methods, 1996
- Liposomes as an immunoadjuvant system for stimulation of mucosal and systemic antibody responses against inactivated measles virus administered intranasally to miceVaccine, 1995
- Engineering liposomes for drug delivery: progress and problemsTrends in Biotechnology, 1995
- Receptor-Linked Antigen Delivery System (R-LADS): Importance of Autologous α2-Macroglobulin in the Development of Peptide VaccineBiochemical and Biophysical Research Communications, 1995
- Anti‐Hepatitis A Virus Antibody Response Elicited in Mice by Different Forms of a Synthetic VP1 PeptideMicrobiology and Immunology, 1995
- Recent advances in liposomal drug-delivery systemsCurrent Opinion in Biotechnology, 1995
- The Immunological Adjuvant and Vaccine Carrier Properties of LiposomesJournal of Drug Targeting, 1994
- Liposomes as carriers of antigens and adjuvantsJournal of Immunological Methods, 1991